However, the fact that the level of CD80 cells is lower in individuals with MI than in the control group, along with a decrease in the level of M2 mf– CD206+ cells by the late period of MI and becoming comparable with CD80+ and stabilin-1 cells, may cause an adverse course of the disease. The gene discussed is STAB1; the disease is myocardial infarction.